| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 45.721 | 45.967 | 57.213 | 62.261 | 69.988 | 70.296 | 81.397 | 80.879 | 105.813 | 122.567 |
| Total Income - EUR | 45.746 | 45.990 | 57.290 | 62.273 | 69.988 | 73.432 | 81.672 | 86.591 | 114.566 | 128.273 |
| Total Expenses - EUR | 33.656 | 36.526 | 47.988 | 49.860 | 47.389 | 54.636 | 46.418 | 50.967 | 67.844 | 71.977 |
| Gross Profit/Loss - EUR | 12.091 | 9.463 | 9.301 | 12.413 | 22.599 | 18.796 | 35.253 | 35.625 | 46.723 | 56.295 |
| Net Profit/Loss - EUR | 10.718 | 9.004 | 8.597 | 11.782 | 21.928 | 18.143 | 34.586 | 35.082 | 45.805 | 52.523 |
| Employees | 4 | 4 | 4 | 3 | 3 | 3 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Hapenciuc Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.104 | 4.175 | 17.762 | 12.146 | 7.458 | 4.860 | -503 | -1.050 | 19.287 | 16.963 |
| Current Assets | 94.194 | 40.395 | 27.938 | 52.446 | 45.438 | 66.078 | 74.001 | 98.754 | 125.032 | 156.274 |
| Inventories | 664 | 657 | 676 | 98 | 0 | 0 | 0 | 0 | 14 | 0 |
| Receivables | 3.333 | 5.654 | 5.862 | 6.429 | 8.662 | 3.527 | 5.305 | 4.983 | 10.509 | 340 |
| Cash | 90.198 | 34.084 | 21.399 | 45.918 | 36.776 | 62.552 | 68.696 | 93.771 | 114.509 | 155.935 |
| Shareholders Funds | 94.883 | 36.116 | 44.101 | 55.074 | 44.368 | 61.670 | 70.631 | 39.521 | 64.991 | 67.181 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 8.415 | 8.454 | 1.599 | 9.519 | 8.529 | 9.268 | 2.868 | 58.183 | 79.329 | 106.056 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Hapenciuc Med Srl